Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| METEORA CAPITAL, LLC | XCBE X3 Acquisition Corp. Ltd. | 13G | 8.88% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | IE Ivanhoe Electric Inc. | 13G/A | 4.29% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | VOYA Voya Financial, Inc. | 13G | 6.6% | Mar 31, 2026 | 6mo |
| Empyrean Capital Partners, LP | OPTU Optimum Communications, Inc. | 13G/A | 5.22% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | CHRD Chord Energy Corp | 13G | 6.7% | Mar 31, 2026 | 6mo |
| Jose Antonio Batista Costa | PICS PicS N.V. | 13G | 9.9% | Mar 31, 2026 | 6mo |
| Avoro Capital Advisors LLC | AVTX Avalo Therapeutics, Inc. | 13G | 5.75% | Mar 31, 2026 | 6mo |
| Balyasny Asset Management L.P. | VSTM Verastem, Inc. | 13G/A | 1.55% | Mar 31, 2026 | 6mo |
| Sourcerock Group LLC | CRC California Resources Corp | 13G | 5.1% | Mar 31, 2026 | 6mo |
| Aeroequity GP, LLC | YSS York Space Systems Inc. | 13G | 23.28% | Mar 31, 2026 | 6mo |
| Omid Farokhzad | SEER Seer, Inc. | 13G/A | 12% | Mar 31, 2026 | 6mo |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | NVNO enVVeno Medical Corp | 13G/A | 5.5% | Mar 31, 2026 | 6mo |
| RTW INVESTMENTS, LP | APLS Apellis Pharmaceuticals, Inc. | 13G/A | 2.9% | Mar 31, 2026 | 6mo |
| Fundsmith LLP | SABR Sabre Corp | 13G/A | 2.3% | Mar 31, 2026 | 6mo |
| Sirenia Capital Management LP | CRVS Corvus Pharmaceuticals, Inc. | 13G | 7.5% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | PMN ProMIS Neurosciences Inc. | 13G | 10% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | AZR Azora Therapeutics, Inc. (DE) | 13G/A | 4.99% | Mar 31, 2026 | 6mo |
| Deep Track Capital, LP | IVA Inventiva S.A. | 13G/A | 3.76% | Mar 31, 2026 | 6mo |
| G1 Execution Services, LLC | NUAI New ERA Energy & Digital, Inc. | 13G | 7.1% | Mar 31, 2026 | 6mo |
| Long Focus Capital Management, LLC | ONIT Onity Group Inc. | 13G | 6.3% | Mar 31, 2026 | 6mo |
| AMERIPRISE FINANCIAL INC | TTI Tetra Technologies Inc | 13G/A | 4.1% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | REKR Rekor Systems, Inc. | 13G/A | 2.04% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | TARS Tarsus Pharmaceuticals, Inc. | 13G | 5.3% | Mar 31, 2026 | 6mo |
| OLP CAPITAL MANAGEMENT Ltd | HUYA HUYA Inc. | 13G/A | 12.5% | Mar 31, 2026 | 6mo |
| BIOTECHNOLOGY VALUE FUND L P | TCRX TScan Therapeutics, Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| Deep Track Capital, LP | GERN Geron Corp | 13G/A | 4.95% | Mar 31, 2026 | 6mo |
| NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | ABEO Abeona Therapeutics Inc. | 13G/A | 5.82% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | CRAN Crane Harbor Acquisition Corp. II | 13G | 8% | Mar 31, 2026 | 6mo |
| BRC Group Holdings, Inc. | DDI DoubleDown Interactive Co., Ltd. | 13G/A | 7.3% | Mar 31, 2026 | 6mo |
| DARLINGTON PARTNERS CAPITAL MANAGEMENT, LP | OS OneStream, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| RTW INVESTMENTS, LP | TNGX Tango Therapeutics, Inc. | 13G | 9.3% | Mar 31, 2026 | 6mo |
| G1 Execution Services, LLC | API Agora, Inc. | 13G/A | 9.4% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | SSNC SS&C Technologies Holdings Inc | 13G/A | 3.5% | Mar 31, 2026 | 6mo |
| VAN ECK ASSOCIATES CORP | IAG Iamgold Corp | 13G/A | 6.42% | Mar 31, 2026 | 6mo |
| RTW INVESTMENTS, LP | CMPS COMPASS Pathways plc | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | KRAQ KRAKacquisition Corp | 13G | 6.51% | Mar 31, 2026 | 6mo |
| Arena Holdings Management LLC | HE Hawaiian Electric Industries Inc | 13G/A | 3% | Mar 31, 2026 | 6mo |
| Velan Capital Investment Management LP | NSPR InspireMD, Inc. | 13G/A | 4.99% | Mar 31, 2026 | 6mo |
| MMCAP International Inc. SPC | EU enCore Energy Corp. | 13G/A | 4.5% | Mar 31, 2026 | 6mo |
| RTW INVESTMENTS, LP | IRTC iRhythm Holdings, Inc. | 13G | 5.2% | Mar 31, 2026 | 6mo |
| PERCEPTIVE ADVISORS LLC | IRD Opus Genetics, Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| Manulife Investment Management (US) LLC | MBLY Mobileye Global Inc. | 13G/A | 4.21% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | VYGR Voyager Therapeutics, Inc. | 13G/A | 5.87% | Mar 31, 2026 | 6mo |
| Coliseum Capital Management, LLC | SONO Sonos Inc | 13G/A | 15.2% | Mar 31, 2026 | 6mo |
| Lind Global Fund II LP | TENX Tenax Therapeutics, Inc. | 13G/A | 0.78% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | NAKA Nakamoto Inc. | 13G/A | 3.71% | Mar 31, 2026 | 6mo |
| RTW INVESTMENTS, LP | VSTM Verastem, Inc. | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| CORBEL CAPITAL PARTNERS SBIC, L.P. | NROM Noble Romans Inc | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| AKRE CAPITAL MANAGEMENT LLC | CCC CCC Intelligent Solutions Holdings Inc. | 13G | 5.2% | Mar 31, 2026 | 6mo |
| Balyasny Asset Management L.P. | RLYB Rallybio Corp | 13G | 7.12% | Mar 31, 2026 | 6mo |